Neurogenesis Inc (CE) (NEUN) Fundamentals

Description
NeuroGenesis, Inc. formulates nutritional supplements used since 1984 to assist in recovery from abuse of Alcohol, Opiates, Cocaine, Valium, etc. Primary product alleviates or eliminates symptoms of Attention Deficit, Hyperactivity Disorder (Since 1991).
Share Info
StatusActive
Market Cap$ 82
Shares Authorized1,000,000,000
Shares Outstanding82,262,136
Shares Outstanding Date12/31/2013
Shareholder Count-
Shareholder Count Date-
Float13,168,504
Float Date04/09/2007
Short Interest3,539
Short Interest Date10/15/2021
Reporting Info
Reporting StatusAlternative Reporting Standard
BankruptNo
ShellNo
Audit Status-
AuditorRussell, Craft & Schulz
Auditor Address1002 Gemini
Suite 130
Houston, Texas 77058
USA
Auditor Website-
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselLewis & Barnes
Legal Counsel Address5248 Larkin Street
Suite A
Houston, Texas 77077
USA
Legal Counsel Website-
Fiscal Year End12/31
ADR Ratio-
Transfer Agent-
Transfer Agent Address-
Depository Website-
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:NEUN
OTC Market TierExpert Market
Security TypeCommon Stock
CIK Number0000848071
Address1241 Butler Road
League City, Texas 77573
CountryUSA
Phone+1 281-557-7877
Fax #281-332-4753
Websitehttp://www.neurogenesis.com
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesVice President - Karen Coady
Dir. - Terry Neher
Dir. - Jeff Lewis
Dir. - Paul Brown
President - Frank Bieser
Number of Employees5
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year1983


Your Recent History
USOTC
NEUN
Neurogenes..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.